Senores Pharma, a company in the Pharmaceuticals industry, reported revenue of ₹192 crore and net profit of ₹37 crore for the September 2026 quarter.
Senores Pharma. (NSE: SENORES) closed at ₹1,090.80 on 20 Nov 2026, up 32.1% over the past year. Its market capitalisation is ₹5,024 crore and it trades at 37.6 times earnings.
Incorporated in 2015, Senores Pharmaceuticals Ltd manufactures and develops affordable and high-quality complex generics certified by global food and drugs authorities
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.